Open AccessRadium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale
Author(s) -
Ramy Sedhom,
Emmanuel S. Antonarakis
Publication year - 2019
Publication title -
translational andrology and urology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2019.05.02
Subject(s) - radium 223 , cabazitaxel , enzalutamide , medicine , prostate cancer , abiraterone acetate , denosumab , docetaxel , oncology , abiraterone , androgen deprivation therapy , cancer , androgen receptor , bone metastasis , osteoporosis